Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
71.62B
Market cap71.62B
Price-Earnings ratio
18.71
Price-Earnings ratio18.71
Dividend yield
Dividend yield
Average volume
18.24M
Average volume18.24M
High today
$48.25
High today$48.25
Low today
$41.49
Low today$41.49
Open price
$42.76
Open price$42.76
Volume
51.28M
Volume51.28M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$41.49
52 Week low$41.49

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $46.00. The company's market cap stands at 71.62B, with a P/E ratio of 18.71.

On 2026-07-29, Boston Scientific(BSX) stock moved within a range of $41.49 to $48.25. With shares now at $46.00, the stock is trading +10.9% above its intraday low and -4.7% below the session's peak.

Trading volume for Boston Scientific(BSX) stock has reached 51.28M, versus its average volume of 18.24M.

The stock's 52-week range extends from a low of $41.49 to a high of $109.50.

The stock's 52-week range extends from a low of $41.49 to a high of $109.50.

BSX News

TipRanks 6h
Boston Scientific price target lowered to $60 from $65 at Stifel

Stifel analyst Rick Wise lowered the firm’s price target on Boston Scientific (BSX) to $60 from $65 and keeps a Buy rating on the shares. The latest round of gu...

Benzinga 8h
Boston Scientific Cuts Forecast on Product Slowdown and Competition

Boston Scientific Corporation (NYSE:BSX) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets....

Boston Scientific Cuts Forecast on Product Slowdown and Competition
Seeking Alpha 11h
Boston Scientific slips as outlook trails consensus

Boston Scientific (BSX) lost nearly 6% in the premarket on Wednesday despite reporting better-than-expected Q2 2026 financials as the medical device maker set i...

Boston Scientific slips as outlook trails consensus

Analyst ratings

88%

of 32 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

More BSX News

The Wall Street Journal 12h
Boston Scientific Cuts Outlook Ahead of Restructuring

Boston Scientific logged higher second-quarter results. Clodagh Kilcoyne / Reuters Boston Scientific BSX 1.21 %increase; up pointing triangle logged higher sec...

Boston Scientific Cuts Outlook Ahead of Restructuring
Nasdaq 13h
Boston Scientific Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - Boston Scientific Corp (BSX) will host a conference call at 8:00 AM ET on July 29, 2026, to discuss Q2 26 earnings results. To access the live webc...

Boston Scientific Q2 26 Earnings Conference Call At 8:00 AM ET
MarketWatch 1d
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

...

Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Simply Wall St 1d
Boston Scientific Recalls Rapid Refill Injection System Over Syringe Detachment Risk

Boston Scientific has issued a voluntary Class II recall of its Rapid Refill Continuous Injection System. The recall is linked to a risk that syringes may loos...

Boston Scientific Recalls Rapid Refill Injection System Over Syringe Detachment Risk
TipRanks 2d
Boston Scientific Launches 2026 Global Restructuring Plan

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 2d
Boston Scientific’s FARAFLEX AFib Trial Steps Up the Pulsed Field Ablation Race

Boston Scientific (BSX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confid...

Simply Wall St 4d
What Boston Scientific's Stronger-Than-Expected Segment Earnings Mean For Shareholders

Earlier this week, Boston Scientific reported quarterly earnings of US$0.83 per share and revenues of US$5.39 billion, both increasing from the prior year, with...

What Boston Scientific's Stronger-Than-Expected Segment Earnings Mean For Shareholders

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.